123I-BMIPP fatty acid analogue imaging is a novel diagnostic and prognostic approach following acute myocardial infarction

Singapore Medical Journal

Volumn 50, Issue 10, 2009, Pages 943-948

  Biswas, Shankar Kumar ^a   Sarai, M ^a   Hishida, H ^a   Ozaki, Y ^a  

^a FUJITA HEALTH UNIVERSITY HOSPITAL   (Japan)

Author keywords

methyl p iodophenylpentadecanoic acid scan; Acute myocardial infarction; Fatty acid metabolism; Ischaemic memory

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; FATTY ACID DERIVATIVE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; TETROFOSMIN; THALLIUM 201; DIAGNOSTIC AGENT; FATTY ACID; IODOBENZENE; IODOFILTIC ACID; OXYGEN; RADIOACTIVE IODINE;

ACUTE HEART INFARCTION; CLINICAL ASSESSMENT; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; DISEASE SEVERITY; EARLY DIAGNOSIS; ENERGY YIELD; FATTY ACID OXIDATION; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART PERFUSION; HEART VENTRICLE FUNCTION; HIGH RISK POPULATION; HUMAN; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; REVIEW; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ADULT; CHEMISTRY; FEMALE; HEART INFARCTION; ISCHEMIA; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RISK; SCINTISCANNING; TREATMENT OUTCOME;

ADULT; FATTY ACIDS; FEMALE; HUMANS; IODINE RADIOISOTOPES; IODOBENZENES; ISCHEMIA; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OXYGEN; PROGNOSIS; RISK; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME;

EID: 74549174815     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Tamaki N, Morita K, Kuge Y. Fatty acid imaging. In: Zaret BL, Beller GA, eds. Clinical Nuclear Cardiology, State of Art and Future Directions. 3rd ed. Philadelphia: Elsevier Mosby 2005: 559-72.
2. Ziessman HA, O'Malley JP, Thrall JH. Cardiac system. In: Nuclear Medicine-The Requisites in Radiology. 3rd ed. Philadelphia: Elsevier Mosby, 2006: 450-507.
3. Taki J, Matsunari I. Metabolic imaging using SPECT. Eur J Nucl Med Mol Imaging 2007; 34 Suppl 1:S34-48.
4. Knapp FF Jr, Kropp J. Iodine-123-labelled fatty acids for myocardial single photon emission tomography. Current status and future perspectives. Eur J Nucl Med 1995; 22:361-81.
5. Tamaki N, Fujibayashi Y, Magata Y, Yonekura Y, Konishi J. Radionuclide assessment of myocardial fatty acid metabolism by PET and SPECT. J Nucl Cardiol 1995; 2:256-66.
6. Tamaki N, Morita K, Kuge Y, Tsukamoto E. The role of fatty acids in cardiac imaging. J Nucl Med 2000; 41:1525-34.
7. Casteels M, Foulon V, Mannaerts GP, Van Veldhoven P. Alpha-oxidation of 3-methyl-substituited fatty acids and its thiamine dependence. Eur J Biochem 2003; 270:1619-27.
8. Knapp FF Jr, Ambrose KR, Goodman MM. New radioiodinated methyl branched fatty acids for cardiac studies. Eur J Nucl Med 1986; 12 Suppl:S39-44.
9. Kobayashi H, Kusakabe K, Momose M, et al. Evaluation of myocardial perfusion and fatty acid uptake using a single injection of iodine-123-BMIPP in patients with acute coronary syndromes. J Nucl Med 1998; 39:1117-22.
10. Matsunari I, Saga T, Taki J, et al. Kinetics of iodine-123-BMIPP in patients with prior myocardial infarction: assessment with dynamic rest and stress images compared with stress thallium-201 SPECT. J Nucl Med 1994; 35:1279-85.
11. Dobbeleir AA, Hambye ASE, Franken PR. Influence of methodology on the presence and extent of mismatching between 99mTc-MIBI and 123I-BMIPP in myocardial viability studies. J Nucl Med 1999; 40:707-14.
12. Furutani Y, Shiigi T, Nakamura Y, et al. Quantification of area at risk in acute myocardial infarction by tomographic imaging. J Nucl Med 1997; 38:1875-82.
13. Kawai Y, Tsukamoto E, Nozaki Y, et al. Use of 123I-BMIPP single-photon emission tomography to estimate areas at risk following successful revascularization in patients with acute myocardial infarction. Eur J Nucl Med 1998; 25:1390-5.
14. Tanaka R, Nakamura T. Time course evaluation of myocardial perfusion after reperfusion therapy by 99mTc-tetrofosmin SPECT in patients with acute myocardial infarction. J Nucl Med 2001; 42:1351-8.
15. Nakata T, Hashimoto A, Eguchi M. Cardiac BMIPP imaging in acute myocardial infarction. Int J Card Imaging 1999; 15:21-6.
16. Tamaki N, Kawamoto M, Yonekura Y, et al. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: assessment with emission tomography using an iodinated branched fatty acid. J Nucl Med 1992; 33:659-67.
17. De Geeter F, Franken P, Knapp FF Jr, Borruyt A. Relationship between blood flow and fatty acid metabolism in subacute myocardial infarction: a study by means of 99mTc- Sestamibi and 123I-beta-methyl-iodo-phenyl pentadecanoic acid. Eur J Nucl Med 1994; 21:283-91.
18. Franken P, De Geeter F, Dendale P, et al. Abnormal free fatty acid uptake in subacute myocardial infarction after coronary thrombolysis: correlation with wall motion and ionotropic reserve. J Nucl Med 1994; 35:1758-65.
19. Kawai Y, Tsukamoto E, Nozaki Y, et al. Significance of reduced uptake of iodinated fatty acid analogue for the evaluation of patients with acute chest pain. J Am Coll Cardiol 2001; 38:1888-94.
20. Franken PR, Dendale P, De Geeter F, et al. Prediction of functional outcome after myocardial infarction using BMIPP and sestamibi scintigraphy. J Nucl Med 1996; 37:718-22.
21. Hambÿe AS, Vervaet A, Dobbeleir A, Dendale P, Franken P. Prediction of functional outcome by quantification of sestamibi and BMIPP after acute myocardial infarction. Eur J Nucl Med 2000; 27:1494-500.
22. Hashimoto A, Nakata T, Tsuchihashi K, et al. Postischemic functional recovery and BMIPP uptake after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction. Am J Cardiol 1996; 77:25-30.
23. Ito T, Tanouchi J, Kato J, et al. Recovery of impared left ventricular function in patients with acute myocardial infarction is predicted by the discordance in defect size on 123-I-BMIPP and 201-Tl SPECT images. Eur J Nucl Med 1996; 23:917-23.
24. Taki J, Kanajima K, Matsunari I, et al. Assessment of improvement of myocardial fatty acid uptake and function after revascularization using iodine-123-BMIPP. J Nucl Med 1997; 38:1503-10.
25. Yoshida S, Ito M, Mitsunami K, Kinoshita M. Improved myocardial fatty acid metabolism after coronary angioplasty in chronic coronary artery disease. J Nucl Med 1998; 39:933-8.
26. Murray G, Schad N, Ladd W, et al. Metabolic cardiac imaging in severe coronary disease: assessment of viability with iodine-123- iodophenylpentadecanoic acid and multicrystal gamma camera, and correlation with biopsy. J Nucl Med 1992; 33:1269-77.
27. Tsubokawa A, Lee JD, Shimizu H, et al. Recovery of perfusion, glucose utilization and fatty caid utilization in stunned myocardium. J Nucl Med 1997; 38:1835-7.
28. Tsuchihashi E, Ueshima K, Uchida T, et al. Transient left ventricular apical ballooning without coronary artery stenosis: a novel heart syndrome mimicking acute myocardial infarction. Angina Pectoris-Myocardial Infarction Investigations in Japan. J Am Coll Cardiol 2001; 38:11-8.
29. Kurisu S, Inoue I, Kawagoe T, et al. Myocardial perfusion and fatty acid metabolism in patients with tako-tsubo-like left ventricular dysfunction. J Am Coll Cardiol 2003; 41:743-8.
30. Higuchi T, Taki J, Nakajima K, et al. Time course of discordant BMIPP and thallium uptake after ischemia and reperfusion in a rat model. J Nucl Med 2005; 46:172-5.
31. Mochizuki T, Murase K, Higashino H, et al. Ischemic "memory image" in acute myocardial infarction of 123I-BMIPP after reperfusion therapy: a comparison with 99mTc-pyrophosphate and 201Tl dual-isotope SPECT. Ann Nucl Med 2002; 16:563-8.
32. Hashimoto A, Nakata T, Tsuchihashi K, et al. Postischemic functional recovery and BMIPP uptake after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction. Am J Cardiol 1996; 77:25-30.
33. Sloof GW, Visser FC, Bax JJ, et al. Increased uptake of iodine-123-BMIPP in chronic ischemic heart disease : comparison with fluorine-18-FDG SPECT. J Nucl Med 1998; 39:255-60.
34. Hammermeister KE, DeRouen TA, Dodge HT. Variables predictive of survival in patients with coronary artery disease. Selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluations. Circulation 1979; 59:421-30.
35. Becker LC, Silverman KJ, Bukley BH, et al. Comparison of early thallium-201scintigraphy and gated blood pool imaging for predicting mortality in patients with acute myocardial infarction. Circulation 1983: 67:1272-82.
36. Hambye AS, Dobbeleir AA, Vervaet AM, Van den Heuvel PA, Franken PR. BMIPP imaging to improve the value of sestamibi scintigraphy for predicting functional outcome in severe chronic ischemic left ventricular dysfunction. J Nucl Med 1999; 40:1468-76.
37. Hambye AS, Vervaet A, Dobbeleir A. Quantification of 99Tcm-sestamibi and 123I-BMIPP uptake for predicting functional outcome in chronically ischaemic dysfunctional myocardium. Nucl Med Commun 1999; 20:737-45.
38. Kawamoto M, Tamaki N, Yonekura Y, et al. Combined study of I-123 fatty acid and thallium-201 to assess ischemic myocardium: comparison with thallium redistribution and glucose metabolism. Ann Nucl Med 1994; 8:47-54.
39. Tamaki N, Kawamoto M. The use of iodinated free fatty acids for assessing fatty acid metabolism. J Nucl Cardiol 1994; 1(2 Pt 2): S72-8.
40. Tamaki N, Tadamura E, Kudoh T, et al. Prognostic value of iodine-123 labelled BMIPP fatty acid analogue imaging in patients with myocardial infarction. Eur J Nucl Med 1996; 23:272-9.
41. Schelbert HR. The usefulness of positron emission tomography. Curr Probl Cardiol 1998; 23:69-120.
42. Sato H, Iwasaki T, Toyama T, Kaneko Y, Inoue T, Endo K. Prediction of functional recovery revascularization in coronary artery disease using (18)F-FDG and (123)I-BMIPP SPECT. Chest 2000; 117:65-72.
43. Kageyama H, Morita K, Katoh C, et al. Reduced 123I-BMIPP uptake implies decreased myocardial flow reserve in patients with chronic stable angina. Eur J Nucl Med Mol Imaging 2006; 33:6-12.
44. Huss JM, Levy FH, Kelly DP. Hypoxia inhibits the peroxisome proliferator-activated receptor alpha/ retinoid X receptor gene regulatory pathway in cardiac myocytes: a mechanism for O2-dependent modulation of mitochondrial fatty acid oxidation. J Biol Chem 2001; 276:27605-12.
45. Kim SJ, Peppas A, Hong SK et al. Persistant stunning induces myocardial hibernation and protection: flow/function and metabolic mechanisms. Cir Res 2003; 92:1233-39.
46. Schwaiger M, Schlbert HR, Ellison D, et al. Sustained regional abnormalities in cardiac metabolism after transient ischemia in chronic dog model. J Am Coll Cardiol 1985; 6:336-47.
47. Hambÿe AS, Vaerenberg MM, Dobeleir AA, et al. Abnormal BMIPP uptake in chronically dysfunctional myocardial segments: correlation with contractile response to low-dose dobutamine . J Nucl Med 1998; 39:1845-50.
48. Suzuki A, Takada Y, Nagasaka M, et al. Comparison of resting beta-methyl-iodophenyl pentadecanoic acid (BMIPP) and thallium-201 tomography using quantitative polar maps in patients with unstable angina. Japan Circ J 1997; 61: 133-8.
49. Yamabe H, Fujiwara S, Rin K, et al. Resting 123I-BMIPP scintigraphy for detection of organic coronary stenosis and therapeutic outcome in patients with chest pain. Ann Nucl Med 2000; 14:187-92.
50. Kataoka K, Nohara R, Hosokawa R, et al. Myocardial lipid metabolism in compensated and advanced stages of heart failure: evaluation by canine pacing model with BMIPP. J Nucl Med 2001; 42:124-9.
51. Inubushi M, Tadamura E, Kudoh T, et al. Simultaneous assessment of myocardial free fatty acid utilization and left ventricular function using 123I-BMIPP-gated SPECT. J Nucl Med 1999; 40:1840-7.
52. Nanasato M, Ando A, Isobe S, et al. Evaluation of left ventricular function using electrocardiographically gated myocardial SPECT with (123)I-labeled fatty acid analog. J Nucl Med 2001; 42:1747-56.
53. Yoshinaga K, Tahara M, Torii H, Kihara K. Predicting the effects on patients with dilated cardiomyopathy of beta-blocker therapy, by using iodine-123 15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP) myocardial scintigraphy. Ann Nucl Med 1998; 12:341-7.
54. Kurata C, Tawarahara K, Taguchi T, et al. Myocardial emission computed tomography with iodine-123-labeled beta-methyl-branched fatty acid in patients with hypertrophic cardiomyopathy. J Nucl Med 1992; 33:6-13.
55. Ohtsuki K, Sugihara H, Kuribayashi T, Nakagawa M. Impairment of BMIPP accumulation at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy. J Nucl Med 1999; 40:2007-13.
56. Tadamura E, Kudoh T, Hattori N, et al. Impairment of BMIPP uptake precedes abnormalities in oxygen and glucose metabolism in hypertrophic cardiomyopathy. J Nucl Med 1998; 39:390-6.